Scilex Holding Company Operating Lease, Payments
Scilex Holding Company (SCLX) reported Operating Lease, Payments of $1.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-14
- Scilex Holding Company operating lease, payments for the quarter ending 2026-06-30 was $312.00K.
- Scilex Holding Company operating lease, payments for the quarter ending 2026-03-31 was $1.10M, a 386.78% increase year-over-year.
- Scilex Holding Company operating lease, payments for the quarter ending 2025-12-31 was $912.00K, a 19.37% increase year-over-year.
- Scilex Holding Company operating lease, payments for the quarter ending 2025-09-30 was $0.00.
- Scilex Holding Company operating lease, payments for fiscal 2025 was $1.14M, a 9.31% increase from fiscal 2024.
- Scilex Holding Company operating lease, payments for fiscal 2024 was $1.04M, a 2.06% increase from fiscal 2023.
- Scilex Holding Company operating lease, payments for fiscal 2023 was $1.02M, a 36.86% increase from fiscal 2022.
- Scilex Holding Company operating lease, payments for fiscal 2022 was $746.00K, a 14.07% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.42M 10-Q · filed 2026-08-14 | $2.33M derived: sum of 3 quarters · filed 2026-08-14 | $2.33M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $1.10M 10-Q · filed 2026-05-20 | $2.02M derived: sum of 2 quarters · filed 2026-05-20 | $2.02M derived: sum of 3 quarters · filed 2026-05-20 | $2.02M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $912.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $912.00K derived: sum of 2 quarters · filed 2026-04-10 | $912.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.14M 10-K · filed 2026-04-10 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $227.00K 10-Q · filed 2025-11-14 | $991.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $227.00K 10-Q · filed 2026-08-14 | $991.00K derived: sum of 3 quarters · filed 2026-08-14 | $991.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $227.00K 10-Q · filed 2026-05-20 | $991.00K derived: sum of 2 quarters · filed 2026-05-20 | $991.00K derived: sum of 3 quarters · filed 2026-05-20 | $992.00K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-12-31 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $764.00K derived: sum of 2 quarters · filed 2026-04-10 | $765.00K derived: sum of 3 quarters · filed 2026-04-10 | $1.04M 10-K · filed 2026-04-10 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.00K derived: sum of 2 quarters · filed 2025-11-14 | $278.00K 10-Q · filed 2025-11-14 | $259.00K 10-Q · filed 2025-01-17 | $555.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $278.00K 10-Q · filed 2025-08-13 | $555.00K derived: sum of 3 quarters · filed 2025-08-13 | $825.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $277.00K 10-Q · filed 2025-05-14 | $554.00K derived: sum of 2 quarters · filed 2025-05-14 | $824.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.08M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $547.00K derived: sum of 2 quarters · filed 2025-03-31 | $805.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.02M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | $528.00K derived: sum of 2 quarters · filed 2025-01-17 | $744.00K 10-Q · filed 2025-01-17 | $959.00K derived: sum of 4 quarters · filed 2025-01-17 | |
| 2023-06-30 | $258.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $474.00K 10-Q · filed 2024-08-13 | $689.00K derived: sum of 3 quarters · filed 2024-08-13 | $886.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $216.00K 10-Q · filed 2024-05-13 | $431.00K derived: sum of 2 quarters · filed 2024-05-13 | $628.00K derived: sum of 3 quarters · filed 2024-05-13 | $795.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $412.00K derived: sum of 2 quarters · filed 2024-03-12 | $579.00K derived: sum of 3 quarters · filed 2024-03-12 | $746.00K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $364.00K derived: sum of 2 quarters · filed 2023-11-14 | $531.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $334.00K 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | $167.00K 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | $654.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |